| Source | Grant Number | Proj. Title |
| NIH | 1R01AG007348 | MPTP & Aging--Molecular/Morphological Correlates |
| NIH | 1R01NS027365 | MPTP-Metabolic Activation & Mechanisms of Cell Death |
| NIH | 3 RO1 AG009121-03S3 | Detecting Preclinical Parkinsonism in Humans |
| NIH | 1R01AG009121 | Aging & Environmental Toxins |
| NIH | 1U10NS031321 | Twin Studies in Parkinson's Disease |
| NIH | 1R01NS033356 | In-Vivo Probes of Nigrostriatal Cell Degeneration (subcontract w/UCLA) |
| NIH | 1R01NS032408 | Neural Transplantation in MPTP-lesioned Model |
| NIH | 1R03ES008627 | Pesticides & Parkinson's Disease |
| NIH | 1R13ES009220 | Neurotoxicity & Neurodegeneration--Biological Links |
| NIH | 1R01NS034886 | Mechanisms of Dopa-Dyskinesias in Parkinsonian Models |
| EPA | R 827017-01-0 | Genetic Polymorphisms in Xenobiotic Metabolism as Susceptibility Factors for Parkinson’s Disease |
| NIH | 1R01NS040065 | A Model for Inflammation & PD |
| NIH | 1RO1 ES10442 | Synuclein Aggregration & Neurodegeneration in PD |
| NIH | 1RO1 ES10806 | Interactions Between Alpha-synuclein/Metals/Pesticides |
| NIH | 1R01ES010803 | Pesticides & Risk in Agricultural Health Study |
| NIH | 1R01NS040467 | Twins & Risk of PD: A Clinical & Imaging Study |
| NIH | 1 RO1 NS31964 | Environmental & Genetic Risks for PD (subcontract w/Stanford) |
| NIH/Roch. | 1 RO1 NS42240 | PANDAS & Strep Infection: Are they linked (subcontract w/Univ.of Rochester) |
| DOD | DAMD17-02-1-0171 | Oligomeric Synuclein & MMP In Parkinson's Disease |
| NIH | 1R21ES011943 | Skin Pigmentation & Parkinson's Disease Risk |
| NIH | 1U54ES012077 | Environmental, Genetic & Cellular Determinants of PD (overall CCPDER funding) |
| NIH | 1U54ES012077-1001 | Genes, Environment & PD: Studies in 4 Unique Cohorts (CCPDER Project I) |
| NIH | 1U54ES012077-1001-S | Epi Methods Working Group (CCPDER Project 1 supplement) |
| NIH | 1U54ES012077-1002 | Neurotoxicants, Oxidative Stress & Synuclein in PD (CCPDER Project II) |
| NIH | 1U54ES012077-1003 | Iron, Oxidative Stress & Pesticides in PD (CCPDER Project III - Buck Institute) |
| NIH | 1U54ES012077-1004 | Nicotine & Neuroprotection in Nonhuman Primates (Project IV) |
| NIH | 1U54ES012077-019000 | Core A - Administration (CCPDER) |
| NIH | 1U54ES012077-019001 | Core B - Information & Outreach (CCPDER) |
| NIH | 1U54ES012077-019002 | Core C - Research & Development (CCPDER) |
| NIH | 1U54ES012077-03S1 | Toxicant-induced Alpha-Synuclein Pathology in Primates |
| NIH | 5U10NS044465 | Large Simple Neuroprotective Trials in PD |
| NIEHS | 1025021177-US-01 | Symposium on Nicotine and Parkinson's disease |
| NIH | 1RO1 NS42091 | Nicotinic Receptors In An Animal Model of PD |
| NIH/UCSD | 1P01NS044233 | Risk Factors for MSA (subcontract w/UCSD) |
| NIH | 1RO1 NS47162 | Nicotine and Neuroprotection in a Parkinson's Mouse Model |
| DOD | W81XWH-04-1-0404 | Large Scale Single Nucleotide Polymorphism….PD Susceptibility |
| DOD | W81XWH-04-1-0490 | Polychlorinated BiPhenyls, Organochlorines, & PD Risk: A Study of Alaskan Natives |
| NIH | 1RO1 NS046340-01A1 | Epidemiiology of Dystonia in a Multi-Ethnic Population |